BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  GLP-1

  Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’

  Analysts will be watching as a generic version of semaglutide—marketed by Novo Nordisk as Wegovy for weight loss—launches in Canada as a test case for future price erosion in the U.S.

  April 29, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Huntington’s disease

  Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval

  Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more than 50%. Analysts say the decision to initiate a last-stage trial reflects a lack of confidence in an accelerated FDA nod.

  April 29, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  Amgen, AstraZeneca join FDA effort harnessing cloud for real-time clinical trials

  The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the cloud—a system that could “compress drug development timelines,” Jefferies analysts said.

  April 29, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• Press Releases

  Agios Reports First Quarter 2026 Financial Results and Provides Business Update

  April 29, 2026

   · 

  11 min read
• Press Releases

  Regeneron Reports First Quarter 2026 Financial and Operating Results

  April 29, 2026

   · 

  30 min read
• Press Releases

  Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

  April 29, 2026

   · 

  8 min read
• Press Releases

  Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

  April 29, 2026

   · 

  15 min read
• Press Releases

  Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

  April 29, 2026

   · 

  19 min read
• 

  Adcomms

  AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questions

  In briefing documents released Wednesday, the FDA raises doubts about two AstraZeneca assets set to be discussed Friday at the agency’s first drug-related advisory committee meeting in nine months.

  April 29, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• Press Releases

  Anika Reports First Quarter 2026 Financial Results

  April 29, 2026

   · 

  16 min read